Defective replication of psoralen adducts detected at the gene-specific level in xeroderma pigmentosum variant cells. by Misra, R R & Vos, J M
MOLECULAR AND CELLULAR BIOLOGY, Feb. 1993, p. 1002-1012
0270-7306/93/021002-11$02.00/0
Copyright X 1993, American Society for Microbiology
Defective Replication of Psoralen Adducts Detected at the
Gene-Specific Level in Xeroderma Pigmentosum Variant Cells
R. RITA MISRA,'t AND JEAN-MICHEL H. VOS12*
UNC-Lineberger Comprehensive Cancer Center' and Department ofBiochemistry and Biophysics, 2
University ofNorth Carolina at Chapel Hill, North Carolina 27599-7295
Received 9 June 1992/Returned for modification 12 October 1992/Accepted 4 November 1992
Replication of damaged DNA is suspected to play an important role in cell cycle, genetic stability, and
survival pathways. Using psoralen photoaddition as prototype DNA damage and the renaturing agarose gel
electrophoresis technique to measure DNA cross-linking in individual genes, Vos and Hanawalt previously
observed efficient bypass replication of psoralen monoadducts in human genes (J.-M. H. Vos and P. C.
Hanawalt, Cell 50:789-799, 1987). To understand the mechanism of bypass replication in human cells, mutants
affected in such a process would be useful. We now report that cells from individuals suffering from the
hereditary recessive syndrome xeroderma pigmentosum variant (XPV) are hypersensitive to killing induced by
photoactivated psoralen. In addition, analysis of psoralen-mediated DNA cross-linking in the rRNA genes
indicated that although repair of psoralen adducts was similar to that of normal individuals, XPV cells were
markedly deficient in the ability to bypass psoralen adducts during replication; in comparison with normal
cells, approximately half as many monoadducts were bypassed during replication in XPV cells. Furthermore,
in contrast to normal cells, replication of interstrand cross-links was not detected in XPV. This is the first
demonstration of a deficiency in bypass replication detected at the gene-specific level in vivo. A model involving
a strand-specific defect in recombinational bypass in XPV is proposed.
DNA damage in living organisms can result in birth
defects, cancer, or lethality. Furthermore, existing data
suggest that relaxation in the control over DNA replication
plays a critical role in determining the pathological response.
For example, errors leading to mutation most often arise
during S phase (16, 21), highly proliferative cells appear to be
more susceptible to neoplastic transformation than nonpro-
liferating cells (13), and overreplication of DNA seems to
promote genetic instability (24). As of yet, however, the
cellular response to damage encountered at the replication
fork, particularly in eukaryotes, is poorly understood (re-
viewed in reference 32).
The existence of several human, hereditary cancer-prone
diseases further suggests that abnormal processing of DNA
damage may be an essential factor in the induction of genetic
alterations (14). Xeroderma pigmentosum (XP) exemplifies
such a disease. An autosomal, recessively inherited disor-
der, XP affects between 1 in 40,000 and 1 in 200,000
individuals worldwide. XP patients are identified by a
marked hypersensitivity to 254-nm UV radiation, resulting in
malignancies of the eyes and sun-exposed areas of the skin,
frequent neurological complications, and premature death.
So far, eight genetic complementation groups have been
identified for XP, indicating that at least eight different genes
may be involved (reviewed in references 4, 11, and 30).
Although deficiencies in the ability to remove damage from
cellular DNA appear to be responsible for most cases of XP,
individuals suffering from the variant form of XP (XPV) have
no obvious defect in DNA repair. XPV cells do, however,
exhibit moderate hypersensitivity to killing induced by UV
light and exaggerated delays in the recovery of DNA syn-
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thesis after treatment with UV light (17, 23). Like those with
classical XP, XPV individuals suffer from an increased risk
of skin cancer, although the average age of onset for XPV
appears later, i.e., 15 and 53 years, respectively (4, 11).
XPV cells are therefore uniquely well suited for use in
experiments aimed at elucidating the relationship between
cellular transformation and aberrant replication of damaged
DNA.
Previous studies have demonstrated an abnormal replica-
tion pattern in XPV cells after irradiation with UV light (17,
23). Although a replication defect in XPV has been proposed
(17, 23), no study has directly compared the ability of the
replication fork to bypass UV-induced damage in normal and
XPV cells. Our strategy to understand the molecular defect
in XPV was based on the use of photoactivated 4'-hy-
droxymethyl 4,5',8-trimethyl psoralen (HMT) as a model
DNA-damaging agent. Since photoactivated HMT produces
adducts that are structurally quite similar to UV-induced
pyrimidine dimers (3), we suspected that XPV cells might be
particularly sensitive to this agent. In addition, the spectrum
of lesions produced by HMT is well defined, limited to
intrastrand monoadducts (MAs) and interstrand cross-links
(XLs) in the genetic material (31, 33). Finally, psoralen MAs
represent a unique lesion, since the bypass efficiency can be
accurately measured at the gene-specific level in cultured
mammalian cells (31), and this bypass level is found to be
extremely high in mammalian genes (33, 38).
Analysis at the gene-specific level was performed to
distinguish whether XPV cells are defective in bypassing or
removing damage encountered at the replication fork. The
renaturing agarose gel electrophoresis (RAGE) technique
(31, 33) was used to monitor induction, removal, and repli-
cational bypass of HMT adducts in the rRNA genes of
normal and XPV cells. Psoralen-induced intrastrand adducts
are bypassed at an efficiency of 80 to 100% during replication
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of the rRNA genes in normal mammalian cells (38), and
tightly regulated expression of the rRNA locus is critical for
normal cell function, differentiation, and growth (26). To-
gether, such observations suggest that the rRNA genes are
particularly good loci to use in studies aimed at understand-
ing how functional DNA processing systems prevent neo-
plastic transformation.
We report that XPV cells are hypersensitive to the cyto-
toxic effects of photoactivated psoralen. In addition, al-
though we found no differences in induction or removal of
psoralen-induced DNA damage between normal and XPV
cells, the XPV cells exhibited a marked deficiency in the
ability to bypass psoralen adducts during replication. Our
results represent the first report of a defect in bypass
replication detected at the gene-specific level in a human cell
line. We speculate that this defect, as applied to UV-induced
damage, may ultimately be responsible for the increased
susceptibility to UV-induced carcinogenesis observed in
individuals with XPV.
MATERIALS AND METHODS
Cell cultures. The XPV lymphoblastoid cell line GM0
2449A was obtained from the National Institute of General
Medical Sciences Human Genetic Mutant Cell Repository
(Camden, N.J.). Normal human lymphoblastoid cell lines
UC729-6 (UC) and HSC93 were gifts from R. Levy and M.
Buchwald, respectively. Cells were grown in suspension in a
humidified atmosphere at 37°C and 5% CO2 in RPMI 1640
medium supplemented with 10% fetal calf serum, glutamine,
and antibiotics. Cultures were routinely split twice per week
and seeded at a density of 2 x 105 to 3 x 105 cells per
100-mm-diameter dish.
Assay of HMT-induced cytotoxicity. The protocol used for
monitoring chemically induced inhibition of cell growth has
been described previously (20) and is similar to the viability
test used to document the UV sensitivity of XPV lympho-
blastoid lines (22). Briefly, growing cells were diluted to a
concentration of 2 x 105/ml and seeded into individual wells
of a 24-well plate. The various doses of HMT (HRI Associ-
ates, Berkeley, Calif.) were administered to cells in phos-
phate-buffered saline and were activated in situ by a single
5-min exposure to 360-nm ultraviolet (UVA) light, and the
unbound HMT was subsequently washed away. Cells in the
first experimental group (PUVA-1 group) were then returned
to 37°C and allowed to recover for various lengths of time.
Cells in the second experimental group (PUVA-2 group)
received an additional 15 min of UVA irradiation prior to
recovery, immediately after removal of unbound HMT.
Previous work has shown that PUVA-1 treatment produces
a high (9:1) ratio of cross-linkable MAs to interstrand XLs in
DNA, and that most (70%) of these MAs are converted to
XLs during the second UVA irradiation of PUVA-2-treated
cells (31, 33, 34). By using a Coulter Counter, increases in
cell number were monitored over a period of 2 weeks. For
both experimental groups, cell growth was monitored 1, 4, 7,
and 14 days posttreatment and reported directly as cell
numbers per milliliter of culture.
Gene-specific analysis of induction, removal, and replica-
tional bypass of HMT-induced damage. The experimental
scheme used to monitor cellular processing of HMT MAs
and XLs in specific fragments of DNA has been described
previously (31, 33). In damage induction studies, cells were
lysed immediately after PUVA-1 treatment to determine the
initial level of damage in cellular DNA. In damage removal
and replicational bypass studies, a portion of each cell type
underwent an additional 24-h posttreatment incubation in
fresh medium containing 10 ,uM bromodeoxyuridine and 1
,uM fluorodeoxyuridine in order to incorporate density label
into newly synthesized DNA. After treatment, cells were
lysed overnight at 37°C in a buffer containing 10 mM Tris, 1
mM EDTA, 0.5% sodium dodecyl sulfate (pH 8), and 0.1 mg
of proteinase K per ml, and cell lysates were treated with
heat-inactivated RNase A. High-molecular-weight DNA was
subsequently purified by phenol-chloroform extraction and
ethanol precipitation and digested with restriction endonu-
clease EcoRI.
In damage removal and bypass studies, unreplicated
(light-light [LL]) fragments of DNA were separated from
replicated (heavy-light [HL]) fragments of DNA by using
two successive, isopycnic CsCl density gradients. Individual
LL and HL samples were then dialyzed overnight, and DNA
concentrations were determined byA260 and/or the Hoechst
dye method (2). In all experiments, the RAGE technique was
used to separate chemically cross-linked and un-cross-linked
fragments of DNA. After separation, the DNA was trans-
ferred to nylon membranes (Micron Separations Inc., West-
boro, Mass.) and hybridized to a 32P-labeled probe as
instructed by the manufacturer. The plasmid probe used in
these studies, PCEB, was provided by J. Sylvester; PCEB
detects a 10.7-kb EcoRI fragment that begins upstream from,
and includes, the 5' end of the human repetitive rRNA gene
(15). Quantitation of autoradiogram band intensities was
achieved with a scanning densitometer (LKB 2222-020 Ul-
troscan XL, equipped with Gel Scan XL software). To
compensate for the detection limits of the X-ray film, both
long and short exposures were often performed; in such
cases, band intensities were standardized to correct for
differences in the lengths of X-ray exposure and radioactive
decay.
To determine the absolute level of psoralen damage in the
rRNA loci of cells treated with various doses of HMT, the
mean numbers of XLs and MAs per fragment were calcu-
lated by using the following equations derived from a Pois-
son distribution (31):
XL= -ln(1- RF) (1)
where XL represents the number of XLs per fragment and
RF represents the fraction of renatured DNA, and
MA = [XLuva- XL] = [ln(1- RF) - ln(1 - RFuva)] (2)
where MA represents the number of MAs per fragment, XL
and XLu,a represent the number of XLs per fragment before
and after in vitro UVA, respectively, and RF and RFuva
represent the fraction of renatured DNA before and after ir.
vitro UVA respectively.
For the quantitation of PUVA-mediated modification of
specific genomic fragments, the following equation was used
to determine the levels of XLs and MAs per fragment at the
various HMT concentrations (31):
RF = DS/(DS + SS)
where DS is the intensity of the double-strand band and SS
is the intensity of the single-strand band in an alkali-treated
sample of DNA. The mean number of XLs per fragment is
derived from the alkali denatured samples, whereas the
mean number of MAs per fragment is derived from the in
vitro extensively UVA-irradiated and denatured samples,
after subtraction of the mean number of XLs per fragment.
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For the quantitation of repair and replication of PUVA-
induced adducts on specific genomic fragments, the follow-
ing equation was used to compare the levels of psoralen
damage between 0 and 24 h in unreplicated DNA and
between unreplicated (LL) and replicated DNA (HL) at 24 h,
respectively (31):
RF = DSa/DSn (4)
where DSn is the intensity of the double-strand band in a
neutral sample, and DSa is the intensity of the double-strand
band in an alkali-treated sample of the same fraction of
DNA. As for equation 3, the frequency of XLs is determined
directly from denatured DNA and the frequency of MAs is
determined from the additional XLs produced by exten-
sively irradiating the DNA in vitro, prior to RAGE.
The efficiency of repair refers to the fraction of lesions
removed from unreplicated DNA during the 24-h recovery
period and has been defined previously (31, 35). The effi-
ciency of replicational bypass refers to the fraction of
damage remaining in newly synthesized DNA, multiplied by
2 to correct for semiconservative replication (31, 38), and is
calculated as follows:
bypass efficiency = [(MAH[IMALL) x 2] (5)
where (MAHL/MALL) represents the fraction of MAs in
replicated DNA relative to unreplicated DNA 24 h after
psoralen exposure with MAHL and MALL defined as in
equation 2.
RESULTS
Psoralen-induced inhibition of normal and XPV cell growth.
To determine whether XPV cells are hypersensitive to
psoralen treatment, dose-response experiments were per-
formed by using a well-established assay to measure inhibi-
tion of cell growth (20, 22). Data collected from five inde-
pendent experiments during a 2-week period after PUVA
treatment are summarized in Fig. 1. As shown, similar
trends in the inhibition of growth of normal and XPV cells
were observed 4, 7, or 14 days after psoralen exposure. In
experiments using conditions that produce 80 to 90% MAs in
cellular DNA (PUVA-1 experiments [34]), a single adminis-
tration of 0.01 ,ig of photoactivated HMT per ml inhibited
the growth of XPV cell cultures by 95%; in contrast, the
same dose caused less than 40% reductions in the growth of
two different normal cell lines. Differences between normal
and XPV cells could not be accurately assessed at higher
PUVA-1 doses; at such doses, growth of all three lines fell to
within the variation in initial seeding of culture wells. In a
second series of experiments using conditions that produce
approximately 70% XLs in cellular DNA (PUVA-2 experi-
ments [34]), XPV hypersensitivity was apparent at the
intermediate HMT doses of 0.003 and 0.005 jig/ml. At these
doses, growth of XPV cultures was inhibited by 84 and 94%,
respectively, whereas growth of normal cells was inhibited
by only 34 and 67%, respectively. Again, at higher PUVA-2
doses, differences between normal and XPV cells were
obscured. Finally, although PUVA-2 conditions appeared to
kill both normal and XPV cells more efficiently than did
PUVA-1 conditions, XPV hypersensitivity relative to nor-
mal cells was more pronounced under PUVA-1 conditions
than under PUVA-2 conditions. This last observation sug-
gests that XPV cells are more hypersensitive to MAs than to
XLs in the genetic material.
Induction of psoralen MAs and XLs in the rRNA loci of
normal and XPV cells. To determine whether an increased
level of DNA modification is responsible for XPV hypersen-
sitivity to PUVA, initial levels of psoralen-induced MAs and
XLs were measured in the rRNA loci of normal (HSC93) and
XPV cells, using the RAGE procedure (Fig. 2a). This
method allows quantitation of extremely low levels of cross-
linking in specific DNA sequences (31). As shown in Fig. 3a,
the levels of PUVA-1-induced DNA MAs and XLs are
visualized as rapidly renaturing double-stranded DNA frag-
ments after alkali denaturation, with or without in vitro UVA
irradiation. As shown in Fig. 3b, no significant differences in
XL levels were detected between normal and XPV lines.
Although a cell-specific difference in MA level was apparent
at the highest HMT dose tested (3 jig/ml), at that dose, the
MA level in normal cells exceeded the level detected in XPV
cells. Such results indicate that the DNAs of normal and
XPV cells are equally accessible to HMT modification and
support the conclusion that an increased susceptibility to
induction of DNA damage is not responsible for XPV
hypersensitivity to PUVA. As expected, our results also
confirmed that a single, short UVA photoactivation step
favors formation of HMT MAs over XLs in cellular DNA;
on the average, MA levels were fourfold higher than XL
levels throughout the dose range used.
Removal of HMT adducts in the rRNA loci of normal and
XPV cells. To determine whether a defect in the ability to
repair psoralen damage is responsible for XPV hypersensi-
tivity to PUVA-1, the amount of damage removed from the
rRNA genes was assessed 24 h after treatment by the
procedure described in Fig. 2b. Inspection of Fig. 4 revealed
a decrease in the fractions of both MAs and XLs after 24 h.
In addition, removal of psoralen adducts from the rRNA
genes appeared similar in normal and XPV cells. After
quantitation by densitometer scanning as described in the
Materials and Methods, we determined that the efficiency of
MA removal approached 30%, and that the efficiency of XL
removal approached 70%, in both cell lines. Taken together,
such results indicate that a defect in removal of DNA
damage is not responsible for XPV hypersensitivity to
PUVA-1.
Bypass replication of HMT adducts in the rRNA loci of
normal and XPV cells. To determine whether a defect in
replicational bypass of DNA damage is responsible for XPV
hypersensitivity to PUVA-1, levels of damage in replicated
and unreplicated fragments of DNA were monitored 24 h
after exposure, using the assay outlined in Fig. 2b. The
results are presented in Fig. 5 and quantified in Table 1.
Inspection of Fig. 5 revealed that the fraction of cross-
linkable fragments in the replicated DNA of normal cells was
FIG. 1. Hypersensitivity of XPV cells to treatment by photoactivated psoralen. Control HSC93 (a and d) and UC (b and e) cells and XPV
cells (c and f) were exposed to various HMT concentrations and treated with a single (a to c) or double (d to f) irradiation as described in
Materials and Methods. Cell growth was monitored 1, 4, 7, and 14 days posttreatment, and the average values of two to five independent
experiments with standard deviations are reported as cell numbers per milliliter of culture. For PUVA-1 experiments, cells were untreated
( ) or given an HMT dose of 0.005 (......), 0.01 (- - -), or 0.1 (-- -) ,ug/ml; for PUVA-2 experiments, cells were untreated ( )
or given an HMT dose of 0.003 (......), 0.005 (- - -), or 0.01 (--- -) ,ug/ml.
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FIG. 2. Schematic illustration of the experimental procedures used to monitor processing of psoralen-induced damage at the gene-specific
level. During RAGE, unmodified DNA and DNA containing psoralen MAs are denatured by alkali treatment and migrate at the position of
single-stranded (ss) fragments. Extensive in vitro UVA irradiation converts psoralen MAs into XLs. Psoralen-cross-linked DNA is resistant
to alkali denaturation and migrates at the position of double-stranded (ds) fragments. (a) Initial levels of MAs and XLs are determined
immediately after PUVA-1 treatment by using the RAGE technique; (b) the repair efficiency is determined by comparing the initial level of
damage with the level of damage remaining in unreplicated (LL) DNA 24 h after psoralen treatment. The efficiency of replicational bypass
is determined by comparing the level of damage remaining in LL DNA with the level of damage remaining in replicated (HL) DNA 24 h after
treatment. Brd Urd, bromodeoxyuridine; Frd Urd, fluorodeoxyuridine.
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FIG. 3. Cellular susceptibility to HMT-induced modification of
DNA. (a) Normal and XPV cells were lysed immediately after
treatment with various doses of photoactivated HMT, and DNAwas
isolated, digested with endonuclease EcoRI, and analyzed by
RAGE. Following Southern transfer to nylon membranes, DNAwas
hybridized with a probe that detects a 10.7-kb fragment spanning the
region immediately upstream from, and including, the 5' end of the
rRNA gene. Levels of psoralen adducts are visualized as renatured
double-strand bands in lanes labeled at the bottom as Alkali for XLs
and UVA + Alkali for MAs. Markers on the left indicate the
migration positions of double-stranded (ds) and single-stranded (ss)
DNA fragments. (b) Summary of results from the experiments
shown in panel a. Quantitative analysis of the autoradiograms was
done by scanning densitometry as described in Materials and
Methods. Filled and open circles represent XL levels in normal and
XPV cells, respectively; filled and open squares represent MA levels
in normal and XPV cells, respectively.
3.0
approximately half that in the unreplicated DNA. This
finding reflects efficient bypass replication. In contrast, the
fraction of cross-linkable DNA appeared to be much lower in
the replicated DNA of XPV cells than in the unreplicated
DNA. As indicated in Table 1, 72 to 84% of HMT MAs were
bypassed in normal cells, but only 36 to 51% of these lesions
were bypassed in XPV cells. This result corresponds to 45%
deficiency in bypass of psoralen MAs in the XPV line. In
addition, careful examination of the gels presented in Fig. 5
also revealed that a fraction of psoralen XLs were also
bypassed during normal DNA replication; while an average
of 40% of XLs were found in replicated DNA of normal cells
(Table 1), no such bypass of psoralen XLs was detected in
the XPV cell line. Taken together, these results indicate that
a defect in bypass replication of psoralen adducts may be
responsible for XPV hypersensitivity to PUVA-1.
DISCUSSION
XPV hypersensitivity to psoralen MAs. We report that XPV
cells are hypersensitive to photoactivated psoralen. In dose-
response studies monitoring psoralen-induced inhibition of
cell growth, we determined that XPV cells are especially
hypersensitive to HMT MAs in DNA. Enhanced sensitivity
to psoralen MAs would be predicted if such lesions were to
act as efficient blocks to DNA replication in XPV cells but
not in normal cells. Similarly, the fact that XPV hypersen-
sitivity to psoralen XLs was less pronounced may indicate
that XLs arrest replication comparatively well in both cell
types. The finding that XPV cells are hypersensitive to
psoralen adducts contrasts with reports that XPV cells are
not hypersensitive to another bulky chemical agent, ben-
zo[a]pyrene diol epoxide (BPDE) (1, 5). However, since
BPDE adducts are bypassed rather inefficiently in normal
cells, it is quite conceivable that the XPV defect affects a
bypass pathway that does not operate on lesions induced by
BPDE (5). Alternatively, a BPDE bypass deficiency may fall
below the limit of detection in XPV cells. The present study,
along with those documenting XPV hypersensitivity to UV
light (4, 17, 23) but only mild sensitivity to other chemicals
(7, 19), provide indirect evidence that the proteins involved
in replicational bypass of DNA damage may discriminate
between the various lesions in the mammalian genome.
Since photoactivated HMT produces adducts with cyclobu-
tyl rings to pyrimidines that are structurally quite similar to
UV-induced pyrimidine dimers (3), it is possible that the
efficiency of replication bypass in human cells varies with
the nature of the structural deformation into DNA. Intrigu-
ingly, a similar pathway for the processing of DNA damage
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FIG. 4. Repair analysis of psoralen adducts in the rRNA genes of
normal and XPV cells. Cell lines and incubation times after PUVA
treatment are indicated at the top. Repair of psoralen adducts is
visualized by comparing the amount of renatured double-strand
bands between samples 0 and 24 in lanes labeled either Alkali for
XLs or UVA + Alkali for MAs. Markers ds and ss on the left
indicate the positions of double-stranded and single-stranded DNA
fragments, respectively. Genomic DNA was isolated from growing
cultures of normal HSC93 or XPV cells 0 and 24 h after treatment
with 0.3 jig of photoactivated HMT per ml. After EcoRI restriction
and purification by CsCl equilibrium density gradient centrifugation,
samples of parental DNA (LL) were loaded on a nondenaturing
agarose gel as either native DNA, alkali-denatured DNA, or alkali-
denatured DNA after in vitro UVA irradiation for 30 min. After
electrophoresis, Southern transfer, and hybridization with the
rRNA probe, the filter was exposed to XR film with an intensifying
screen.
induced by UV or PUVA has been reported with use of
human cell transformation by integrative plasmids as the
biological endpoint (34).
Processing of psoralen-induced adducts in normal and XPV
cells. When psoralen-induced modification was assessed in a
region just upstream the rRNA gene, no difference between
normal and XPV lines was detected. In addition, similar
levels of PUVA damage between the two cell lines were
observed in other transcribed or nontranscribed fragments of
the rRNA loci (data not shown). Thus, the DNA of normal
and XPV cells appears to be equally accessible to modifica-
tion by HMT. More important, no difference in the ability to
remove DNA damage was detected between normal human
and XPV cells. Although a number of recently isolated
excision repair genes have been shown to be mutated in
classical cases of XP (28), our findings indicate that XPV
hypersensitivity to PUVA is not caused by a deficiency in
excision repair. Heterogeneity in DNA repair at the species-,
cell-, gene-, strand-, and lesion-specific levels has been well
documented (reviewed in references 25 and 32). Specifically,
we have previously shown that psoralen XLs are removed
more efficiently than MAs in actively transcribed genes in a
variety of mammalian fibroblasts (33, 35, 38). Similar results
were obtained in the present study using human lymphoblas-
toid cells. Between the two different types of lesions, HMT
XLs may induce a greater degree of kinking in cellular DNA
and therefore may be more easily recognized by the proteins
involved in excising damage. Alternatively, normal cells
may have evolved a particularly proficient system for remov-
ing XLs from DNA in order to compensate for the inefficient
bypass of XLs during replication.
By examining the persistence of psoralen-induced damage
in newly synthesized DNA, we discovered that XPV cells
are markedly deficient in the ability to bypass psoralen
adducts during replication. Although we cannot completely
rule out the possibility that XPV cells lack a specific,
replication-coupled mechanism of excision repair, several
pieces of evidence argue against such a hypothesis. Theo-
retically, a defect in the ability to remove adducts during
replication would result in an increased level of modification
in partially replicated fragments of DNA. In our experimen-
tal scheme, this effect would appear either as higher levels of
damage in the LL fraction of DNA in XPV versus normal
cells or as a higher level of bypass replication in the defective
versus the normal cell line; in the present study, neither
result was observed. In addition, the frequency and spec-
trum of mutations induced on a shuttle vector exposed to
UV light and allowed to replicate in normal and XPV cells
have recently been reported (37); this study demonstrated
significant differences in the kinds of mutations induced in
normal versus XPV cells. Such findings further support the
conclusion that XPV cells are not deficient in excision re-
pair but that such cells do lack an efficient, error-free
mechanism for bypassing DNA damage during replication.
Thus, such faithful replication must function to suppress
short-term toxicity and long-term carcinogenesis in normal
human cells.
This study indicates that replication pathways of intra-
strand MAs and interstrand XLs in human cells may share at
least one gene product, the XPV protein. In addition, the
loss of the ability to replicate XLs in XPV cells, together
with recent evidence that both MAs and XLs induce sister
chromatid exchange (6), may suggest that the XPV defect
affects a translesional mechanism involving recombina-
tion (32). A recombination-related defect is proposed be-
cause it is difficult to imagine a simpler alternative mecha-
nism for error-free bypass of XLs. At least two distinct
recombination pathways for bypass replication in human
cells have been proposed (2, 10, 32). The first involves
generalized recombination between the damaged and the
undamaged DNA daughter molecules similar to the prokary-
otic postreplication repair process; the other invokes a
reversible strand-switching mechanism whereby a blocked
new strand anneals with the unblocked new strand of the
daughter molecule, replicates this undamaged template
strand, and reanneals with its original damaged parental
strand (for details, see the review in reference 32). In either
case, the process may involve a continuous or gap-filling
replication/recombination pathway. Thus, XPV could be
defective in any of these processes. Alternatively, the XPV
defect may affect a regulatory component of nuclear repli-
cation which is indirectly involved in bypass replication,
such as progression through the S phase and/or de novo
activation of stress replicons.
Finally, the finding that XPV cells are 45% deficient in the
ability to bypass psoralen MAs suggests two additional
possibilities: either the XPV syndrome is caused by a leaky
mutation or the XPV defect affects only one strand of duplex
DNA (32). Partial deficiencies in human syndromes are not
uncommon (12); in such cases, complete mutations may be
lethal, or too toxic, to allow proper development of an
individual. On the other hand, current models of replication
in human cells suggest that different DNA polymerases
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FIG. 5. Replication analysis of psoralen adducts in the rRNA genes of normal and XPV cells. Replication bypass of psoralen adducts is
visualized by comparing samples HL and LL of lanes labeled either Alkali for XLs or UVA + Alkali for MAs. Growing cultures of normal HSC93
orXPV cells were treated either 0.3 (a) or 1 (b) ,ug of photoactivated HMT per ml, and genomic DNAwas isolated 24 h after treatment. AfterEcoRl
restriction and separation by density gradient centrifugation of unreplicated (LL) and replicated (HL) DNAs (indicated at the top), samples were
loaded on a nondenaturing agarose gel electrophoresis either native, alkali denatured, or alkali denatured after in vitro UVA irradiation (indicated
at the bottom). After electrophoresis, Southern transfer, and hybridization with a radiolabeled rRNA probe, the filters were exposed to XR film with
an intensifying screen. Positions of the double-stranded (ds) and single-stranded (ss) probed fragments are indicated at the left.
TABLE 1. Deficiency in replicational bypass in the rRNA genes of XPV cells
Cell line HMT dose DNA fraction RFa XL" RF,a XL.4 MAC Bypass efficiency"
HSC93 0.3 LL 3.93 0.040 7.30 0.076 0.036
72.2
HL 1.22 0.012 2.44 0.025 0.013
XPV 0.3 LL 1.20 0.012 10.18 0.107 0.095
35.8
HL NDDe ND 1.67 0.017 0.017
HSC93 1.0 LL 14.85 0.161 51.28 0.719 0.558
84.2
HL 1.79 0.018 22.32 0.253 0.235
XPV 1.0 LL 7.25 0.075 26.09 0.302 0.227
51.1
HL ND ND 5.66 0.058 0.058
a Determined according to equation 4."Determined according to equation 1.
c Determined according to equation 2.
d Determined according to equation 5.
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DNA (18), and a leading-strand versus lagging-strand bias
affecting the fidelity of eukaryotic replication has already
been proposed (29, 36). Studies to determine whether the
XPV defect is strand specific or partial on both strands are
currently under way in our laboratory.
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